Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nduaka CI"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Haiying Zhang, Daniel Quirk, Stephen B. Hanauer, Chinyu Su, Deborah A Woodworth, Walter Reinisch, Nervin Lawendy, Chudy I. Nduaka, Peter D.R. Higgins, Adam S. Cheifetz, Gary S. Friedman, Remo Panaccione, Silvio Danese
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:139-147
Tofacitinib is an oral, small molecule inhibitor of JAK for the treatment of ulcerative colitis (UC). We evaluated the onset of symptom improvement in post-hoc analyses of data from 2 phase 3 trials of induction therapy with tofacitinib in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbee5d60f893d5aff7cf8baa99ef6f29
https://doi.org/10.1016/j.cgh.2018.07.009
https://doi.org/10.1016/j.cgh.2018.07.009
Autor:
Sandborn WJ; Division of Gastroenterology, University of California, San Diego, La Jolla, California., Peyrin-Biroulet L; Inserm U1256 and Department of Gastroenterology, Nancy University Hospital, Lorraine University, Vandœuvre lès-Nancy, France., Quirk D; Pfizer Inc, Collegeville, Pennsylvania., Wang W; Pfizer Inc, Collegeville, Pennsylvania., Nduaka CI; Pfizer Inc, Collegeville, Pennsylvania., Mukherjee A; Pfizer Inc, Groton, Connecticut., Su C; Pfizer Inc, Collegeville, Pennsylvania., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: bruce.sands@mssm.edu.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Aug; Vol. 20 (8), pp. 1821-1830.e3. Date of Electronic Publication: 2020 Oct 27.
Autor:
Sands BE; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Long MD; University of North Carolina, Center for Gastrointestinal Biology and Disease, Chapel Hill, North Carolina, USA., Reinisch W; Medical University of Vienna, Vienna, Austria., Panés J; §Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., Loftus EV; ¶Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Nduaka CI; aPfizer Inc, Collegeville, Pennsylvania, USA., Soonasra A; aPfizer Inc, Collegeville, Pennsylvania, USA., Mundayat R; Pfizer Inc, New York, New York, USA., Lawendy N; aPfizer Inc, Collegeville, Pennsylvania, USA., Chan G; aPfizer Inc, Collegeville, Pennsylvania, USA., Friedman GS; aPfizer Inc, Collegeville, Pennsylvania, USA., Su C; aPfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
Inflammatory bowel diseases [Inflamm Bowel Dis] 2022 Feb 01; Vol. 28 (2), pp. 234-245.
Autor:
Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York., Osterman MT; University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania., Thorpe AJ; Pfizer Inc, Collegeville, Pennsylvania., Salese L; Pfizer Inc, Collegeville, Pennsylvania., Nduaka CI; Pfizer Inc, Collegeville, Pennsylvania., Zhang H; Pfizer Inc, Collegeville, Pennsylvania., Lawendy N; Pfizer Inc, Collegeville, Pennsylvania. Electronic address: nervin.lawendy@pfizer.com., Friedman GS; Pfizer Inc, Collegeville, Pennsylvania., Quirk D; Pfizer Inc, Collegeville, Pennsylvania., Su C; Pfizer Inc, Collegeville, Pennsylvania., Reinisch W; Medical University of Vienna, Vienna, Austria.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Jan; Vol. 20 (1), pp. 116-125.e5. Date of Electronic Publication: 2020 Oct 09.
Autor:
Curtis JR; Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA., Regueiro M; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, OH, USA., Yun H; Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA., Su C; Pfizer Inc, Collegeville, PA, USA., DiBonaventura M; Pfizer Inc, New York, NY, USA., Lawendy N; Pfizer Inc, Collegeville, PA, USA., Nduaka CI; Pfizer Inc, Collegeville, PA, USA., Koram N; Pfizer Inc, New York, NY, USA., Cappelleri JC; Pfizer Inc, Groton, CT, USA., Chan G; Pfizer Inc, New York, NY, USA., Modesto I; Pfizer Inc, New York, NY, USA., Lichtenstein GR; Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Aug 19; Vol. 27 (9), pp. 1394-1408.
Autor:
Winthrop KL; Division of Infectious Diseases, Oregon Health & Science University, Portland, OR, USA., Loftus EV; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Baumgart DC; Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada., Reinisch W; Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria., Nduaka CI; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Lawendy N; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Chan G; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Mundayat R; Inflammation and Immunology, Pfizer Inc, New York, NY, USA., Friedman GS; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Salese L; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Thorpe AJ; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Su C; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA.
Publikováno v:
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Jun 22; Vol. 15 (6), pp. 914-929.
Autor:
Lichtenstein GR; Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Rogler G; Department of Gastroenterology and Hepatology, University of Zürich, Zürich, Switzerland., Ciorba MA; Division of Gastroenterology, Washington University in Saint Louis, Saint Louis, Missouri, USA., Su C; Pfizer Inc, Collegeville, Pennsylvania, USA., Chan G; Pfizer Inc, Collegeville, Pennsylvania, USA., Pedersen RD; Pfizer Inc, Collegeville, Pennsylvania, USA., Lawendy N; Pfizer Inc, Collegeville, Pennsylvania, USA., Quirk D; Pfizer Inc, Collegeville, Pennsylvania, USA., Nduaka CI; Pfizer Inc, Collegeville, Pennsylvania, USA., Thorpe AJ; Pfizer Inc, Collegeville, Pennsylvania, USA., Panés J; Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Publikováno v:
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 May 17; Vol. 27 (6), pp. 816-825.
Autor:
Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: bruce.sands@mssm.edu., Taub PR; Division of Cardiovascular Medicine, UC San Diego School of Medicine, La Jolla, California., Armuzzi A; IBD Unit, Presidio Columbus Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy., Friedman GS; Pfizer Inc, Collegeville, Pennsylvania., Moscariello M; Pfizer Inc, Collegeville, Pennsylvania., Lawendy N; Pfizer Inc, Collegeville, Pennsylvania., Pedersen RD; Pfizer Inc, Collegeville, Pennsylvania., Chan G; Pfizer Inc, Collegeville, Pennsylvania., Nduaka CI; Pfizer Inc, Collegeville, Pennsylvania., Quirk D; Pfizer Inc, Collegeville, Pennsylvania., Salese L; Pfizer Inc, Collegeville, Pennsylvania., Su C; Pfizer Inc, Collegeville, Pennsylvania., Feagan BG; Robarts Clinical Trials, Western University, London, Canada.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 Jan; Vol. 18 (1), pp. 123-132.e3. Date of Electronic Publication: 2019 May 08.
Autor:
Sands BE; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Cheifetz AS; Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Nduaka CI; Pfizer Inc, Collegeville, PA, USA., Quirk D; Pfizer Inc, Collegeville, PA, USA., Wang W; Pfizer Inc, Collegeville, PA, USA., Maller E; Pfizer Inc, Collegeville, PA, USA., Friedman GS; Pfizer Inc, Collegeville, PA, USA., Su C; Pfizer Inc, Collegeville, PA, USA., Higgins PDR; University of Michigan, Ann Arbor, MI, USA.
Publikováno v:
Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 19; Vol. 13 (9), pp. 1217-1226.